USE OF ORTHOCLONE-OKT3 MONOCLONAL-ANTIBODY TO REVERSE ACUTE RENAL-ALLOGRAFT REJECTION UNRESPONSIVE TO TREATMENT WITH CONVENTIONAL IMMUNOSUPPRESSIVE REGIMENS

被引:0
作者
MONACO, A
GOLDSTEIN, G
BARNES, L
机构
[1] HARVARD UNIV,SCH MED,DEPT SURG,BOSTON,MA 02115
[2] ORTHO PHARMACEUT CORP,DIV IMMUNOBIOL,RARITAN,NJ 08869
[3] ORTHO PHARMACEUT CORP,CLIN DEV,RARITAN,NJ 08869
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:28 / 31
页数:4
相关论文
共 7 条
[1]  
[Anonymous], 1983, N ENGL J MED, V309, P809
[2]  
GABER AO, IN PRESS TRANSPLANTA
[3]  
GOLDSTEIN G, 1985, NEW ENGL J MED, V313, P337
[4]  
HAAG BW, IN PRESS TRANSPLANT
[5]  
KAHAN BD, 1985, SURGERY, V97, P125
[6]   A SINGLE INSTITUTION, RANDOMIZED, PROSPECTIVE TRIAL OF CYCLOSPORINE VERSUS AZATHIOPRINE-ANTILYMPHOCYTE GLOBULIN FOR IMMUNOSUPPRESSION IN RENAL-ALLOGRAFT RECIPIENTS [J].
NAJARIAN, JS ;
FRYD, DS ;
STRAND, M ;
CANAFAX, DM ;
ASCHER, NL ;
PAYNE, WD ;
SIMMONS, RL ;
SUTHERLAND, DER .
ANNALS OF SURGERY, 1985, 201 (02) :142-157
[7]   USE OF ANTI-THYMOCYTE GLOBULIN FOR REVERSAL OF ACUTE ALLOGRAFT-REJECTION [J].
SHIELD, CF ;
COSIMI, AB ;
TOLKOFFRUBIN, N ;
RUBIN, RH ;
HERRIN, J ;
RUSSELL, PS .
TRANSPLANTATION, 1979, 28 (06) :461-464